13 completed. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 13 |
Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 5 Versus 10 Units of Insulin in Hyperkalemia Management Insulin regular, Dextrose 50, salbutamol - Hyperkalemia, Potassium Imbalance | Phase 4 | Completed | Oman Medical Speciality Board | 384 | 2023-10-01 | 2025-12-22 |
| A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia LOKELMA 5 GM Powder for Oral Suspension - Hyperkalemia | Phase 4 | Completed | NephroNet, Inc. | 88 | 2022-04-14 | 2024-06-05 |
| Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study Sodium Zirconium Cyclosilicate (SZC), Local standard of care - Hyperkalaemia, Chronic Kidney Disease | Phase 4 | Completed | AstraZeneca | 186 | 2022-03-24 | 2025-11-28 |
| Occurrence of Dyskalemia With Treatment for Hypertension Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg - Hypertension, Potassium Imbalance | Phase 4 | Completed | National Heart Foundation of Bangladesh | 1090 | 2022-01-15 | 2023-07-14 |
| Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients Patiromer Oral Product - Hyperkalemia, Kidney Transplant | Phase 4 | Completed | Oslo University Hospital | 13 | 2021-09-01 | 2023-03-23 |
| Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone Sodium zirconium cyclosilicate, Placebo, Spironolactone - Hyperkalaemia, Heart Failure With Reduced Ejection Fraction | Phase 4 | Completed | AstraZeneca | 366 | 2021-03-08 | 2025-07-09 |
| Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia Salbutamol, Insulin Aspart - Hyperkalemia | Phase 4 | Completed | Nantes University Hospital | 419 | 2019-12-20 | 2026-05-14 |
| Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Patiromer Oral Powder Product - Hyperkalemia, End Stage Renal Disease | Phase 4 | Completed | Duke University | 36 | 2019-06-20 | 2025-05-30 |
| Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet. Patiromer, Research Diet Menu - Chronic Kidney Diseases, Hyperkalemia | Phase 4 | Completed | NYU Langone Health | 3 | 2018-03-12 | 2021-12-01 |
| Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer Patiromer - Hyperkalemia, Kidney Transplant | Phase 4 | Completed | The Rogosin Institute | 8 | 2017-08-01 | 2020-04-13 |
| Patiromer With or Without Food for the Treatment of Hyperkalemia patiromer - Hyperkalemia | Phase 4 | Completed | Relypsa, Inc. | 114 | 2016-02-01 | 2021-05-12 |
| Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients Sodium polystyrene sulfonate, Lactose with carob gum - Hyperkalemia, Chronic Kidney Failure | Phase 4 | Completed | Maisonneuve-Rosemont Hospital | 38 | 2014-02-01 | 2014-10-03 |
| Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) Spironolactone and furosemide - Cirrhosis, Ascites | Phase 4 | Completed | University of Padova | 100 | 2005-04-01 | 2008-09-25 |
Renal Insufficiency, Chronic (3) · Insulin Resistance (2) · Kidney Failure, Chronic (2) · Ascites (1) · Fibrosis (1) · Hypertension (1) · Hypokalemia (1)
Metabolic Diseases (13) · Nutritional and Metabolic Diseases (13) · Water-Electrolyte Imbalance (13) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Chronic Disease (5) · Disease Attributes (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Renal Insufficiency (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Glucose Metabolism Disorders (2)
patiromer (3) · Albuterol (2) · Insulin (2) · Spironolactone (2) · Suspensions (2) · sodium zirconium cyclosilicate (2) · Amlodipine (1) · Furosemide (1) · Insulin Aspart (1) · Lactose (1) · Telmisartan (1) · polystyrene sulfonic acid (1)
AstraZeneca (2) · Duke University (1) · Maisonneuve-Rosemont Hospital (1) · NYU Langone Health (1) · Nantes University Hospital (1) · National Heart Foundation of Bangladesh (1) · NephroNet, Inc. (1) · Oman Medical Speciality Board (1) · Oslo University Hospital (1) · Relypsa, Inc. (1) · The Rogosin Institute (1) · University of Padova (1)
United States (6) · Canada (2) · France (2) · Italy (2) · Spain (2) · United Kingdom (2) · Bangladesh (1) · Belgium (1) · Brazil (1) · Czechia (1) · Hungary (1) · Netherlands (1) · Norway (1) · Oman (1) · Poland (1)
David Goldfarb, MD (1) · Fazilatunnesa Malik, MBBS, FCPS (1) · James Tumlin, MD (1) · Jeremy Whitson, BS (1) · John P Middleton, MD (1) · Jun Lee, MD (1)
PMID 32588430, PMID 12873814, PMID 19570764, PMID 32847923, PMID 37398685, PMID 38878009, PMID 39566872